Latest Close
₹1,184.40
+0.98%
Connecting…
Day Range
-
Full OHLC pending
Volume
-
Full session data pending
50 DMA
₹1,143.89
200 DMA
₹1,013.66
1 year gain / loss
+₹198.25(+20.10%)
₹986.15 → ₹1,184.40· 2025-10-30 to 2026-10-30
Charting by TradingView
This stock does not satisfy the default swing-support rules at the selected chart endpoint. Its price, volume and moving averages remain available for manual research.
Snapshot 2026-11-01 · Financial period Jun 2026 · Consolidated figures where available
Zydus Lifesciences Limited is an India-based life-sciences company with positions across pharmaceuticals and consumer wellness, supported by a MedTech franchise and a global footprint across United States, India and other international markets. Its pharmaceutical business includes integrated pharmaceutical operations with business encompassing the entire value chain in research, development, production, marketing and distribution of pharmaceutical products. Its product portfolio includes active pharmaceutical ingredients, human formulations, and animal health and veterinary. Its consumer products business includes development, production, marketing and distribution of differentiated health and wellness products. It provides biologicals manufacturing sites offering contract development and manufacturing organization services to biopharmaceutical companies globally. Its focused therapy areas include cardiology, anti-diabetes, super specialty areas of oncology and nephrology, and others.
Market Cap
₹1,24,089.48 Cr
P/E
27.02×
Sector -38.72× · above
P/B
4.58×
Sector 4.11× · above
EV / EBITDA
16.42×
Sector 19.14× · below
ROE
18.59%
Sector 0.37%
ROCE
17.35%
Sector 6.55%
ROA
8.57%
Sector -17.04%
Cash Flow / Profit
0.42×
| Period | Revenue | Operating profit | Net profit |
|---|---|---|---|
| Jun 2026 | 8,123.1 +5.2% | 1,306.6 | 952.4 -29.0% |
| Mar 2026 | 7,721.2 +10.7% | 1,659.7 | 1,341.3 +39.0% |
| Dec 2025 | 6,975.9 +11.9% | 1,353.4 | 965.1 -21.8% |
| Sep 2025 | 6,232.2 | 1,687.4 | 1,233.4 |
Dividend
24 Jul 2026 · ₹1